Journal of Clinical Endocrinology & Metabolism, Vol 57, 797-802, Copyright © 1983 by Endocrine Society

ARTICLES

Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation

JH Liu and SS Yen

Despite major efforts, the roles of estradiol (E2) and progesterone (P4) as signals for triggering the midcycle gonadotropin surge in women remain incompletely defined. In the present study, a preovulatory configuration of E2 and P4 levels was achieved during the midfollicular phase of normal women and in hypogondal women (with E2 implants) by stepwise incremental infusions of E2 and P4. During the 96 h of E2 infusion alone, reproducible and concomitant surges of LH and FSH occurred after latency periods of (mean +/- SE) 58 +/- 6.9 and 68.2 +/- 2.6 h in midfollicular and hypogonadal subjects, respectively. The mean duration of the E2-induced surge was shorter for both normal midfollicular (22.7 +/- 3.9 h) and hypogonadal women (21.8 +/- 2.5 h) than is the spontaneous midcycle surge (48 h). When P4 infusion was superimposed 48 h after the initiation of E2 infusion, a LH/FSH surge that approximated the dimension of the spontaneous surge was achieved in both groups of women. For the hypogonadal women, but not midfollicular women, P4 infusion also advanced the surge onset by 14.7 h (P less than 0.001). Our data represent the first unequivocal demonstration that incremental E2 sustained for about 60 h constitutes the ovarian signal for initiating the midcycle gonadotropin surge and that a small increment of P4 secreted by the preovulatory follicle is required to establish the normal dimension of the surge. Thus, P4, although essential for creating a normal gonadotropic surge, operates by synergizing the obligatory action of E2.

This article has been cited by other articles:

				C. R. McCartney, S. K. Blank, and J. C. Marshall Progesterone acutely increases LH pulse amplitude but does not acutely influence nocturnal LH pulse frequency slowing during the late follicular phase in women Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E900 - E906. [Abstract] [Full Text] [PDF]

				J. L Turgeon and D. W Waring Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and L{beta}T2 gonadotropes. J. Endocrinol., September 1, 2006; 190(3): 837 - 846. [Abstract] [Full Text] [PDF]

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				R. F. Casper and M. F. M. Mitwally Aromatase Inhibitors for Ovulation Induction J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 760 - 771. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, I. Mademtzis, P. Vanakara, A. Kallitsaris, G. Stamatiou, C. Kotsovassilis, and I. E. Messinis Evidence That Termination of the Estradiol-Induced Luteinizing Hormone Surge in Women Is Regulated by Ovarian Factors J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 641 - 645. [Abstract] [Full Text] [PDF]

				E. L. Escudero, P. J. Boerrigter, H. J. T. C. Bennink, R. Epifanio, J. A. Horcajadas, F. Olivennes, A. Pellicer, and C. Simon Mifepristone Is an Effective Oral Alternative for the Prevention of Premature Luteinizing Hormone Surges and/or Premature Luteinization in Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2081 - 2088. [Abstract] [Full Text] [PDF]

				G. Weiss, J. H. Skurnick, L. T. Goldsmith, N. F. Santoro, and S. J. Park Menopause and Hypothalamic-Pituitary Sensitivity to Estrogen JAMA, December 22, 2004; 292(24): 2991 - 2996. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992. [Abstract] [Full Text] [PDF]

				S. J. Park, L. T. Goldsmith, and G. Weiss Age-Related Changes in the Regulation of Luteinizing Hormone Secretion by Estrogen in Women Experimental Biology and Medicine, July 1, 2002; 227(7): 455 - 464. [Abstract] [Full Text] [PDF]

				K. Oktay, K. Economos, M. Kan, J. Rucinski, L. Veeck, and Z. Rosenwaks Endocrine Function and Oocyte Retrieval After Autologous Transplantation of Ovarian Cortical Strips to the Forearm JAMA, September 26, 2001; 286(12): 1490 - 1493. [Abstract] [Full Text] [PDF]

				W. R. Duan, J. L. Shin, and J. L. Jameson Estradiol Suppresses Phosphorylation of Cyclic Adenosine 3',5'-Monophosphate Response Element Binding Protein (CREB) in the Pituitary: Evidence for Indirect Action via Gonadotropin-Releasing Hormone Mol. Endocrinol., August 1, 1999; 13(8): 1338 - 1352. [Abstract] [Full Text]

				I. M. Colin and J. L. Jameson Estradiol Sensitization of Rat Pituitary Cells to Gonadotropin-Releasing Hormone: Involvement of Protein Kinase C- and Calcium-Dependent Signaling Pathways Endocrinology, September 1, 1998; 139(9): 3796 - 3802. [Abstract] [Full Text] [PDF]

				A. E. Herbison Multimodal Influence of Estrogen upon Gonadotropin-Releasing Hormone Neurons Endocr. Rev., June 1, 1998; 19(3): 302 - 330. [Abstract] [Full Text]

				H. Fujiwara, T. Honda, M. Ueda, K. Nakamura, S. Yamada, M. Maeda, and T. Mori Laminin Suppresses Progesterone Production by Human Luteinizing Granulosa Cells via Interaction with Integrin {alpha}6{beta}1 J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2122 - 2128. [Abstract] [Full Text] [PDF]

				E. Baulieu Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor Science, September 22, 1989; 245(4924): 1351 - 1357. [Abstract] [PDF]